CB2 Insights’ CEO Pradyum Sekar recently sat down with Barrington Miller to discuss the importance of medically validated cannabis data (3:45), the challenge of breaking down barriers with physicians (9:45), and the impact of big pharma on medical cannabis (13:30). Listen until the end to hear about Prad’s experience around launching the company, pivoting the business (hint – vertical integration!), and their recent launch on the CSE – Canadian Securities Exchange.
CSE’s Barrington Miller was joined by Mike Sieb, Director of Getchell Gold Corp. (CSE:GTCH) to inaugurate the first ever “Mining Monday” session of #HashtagFinance. In this discussion, Mike shares why Nevada is his favourite jurisdiction for mineral exploration (4:24), the hallmarks of great opportunities in the mining business (7:22), and the factors that are supporting…
CSE’s Barrington Miller recently sat down with Sahar Ayinehsazian, Attorney at Vicente Sederberg, to discuss the many reasons why there is an increasing demand for legal advice from cannabis operators in the US during the COVID-19 pandemic. In this discussion, Sahar shares how Vincente Sederberg is purpose-built as a cannabis law firm to best serve…
The CSE’s Barrington Miller sat down with Jason Ackerman, the CEO of TerrAscend Corp. (CSE:TER) to dig deeper into his vision for the company as the recently appointed CEO of the organization. In this discussion, the reformed banker and online grocer shares how his past experiences have equipped him for a career in cannabis, including…
